Skip to main content
Log in

Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

For a compound to inhibit potently the transformation of amorphous calcium phosphate into hydroxyapatite, it is suggested that the minimum structural requirement is a phosphate group and, at some other position, either another phosphate group preferably or a carboxylic moiety. Primary amino groups abolish inhibitor potential. Inhibitor potency is modified by various secondary factors, including the number and proximity of active groups, their stereochemistry, steric factors, the lability of the molecule, and in special instances its lipophilicity. Parameters used to monitor the transformation indicate that inhibitors can be grouped into two classes, and it is suggested that this is because one class acts as a hydroxyapatite crystal growth inhibitor. The close proximity of two phosphate groups or of a phosphate and multiple carboxylic groups is proposed to determine in part whether or not a compound acts as a crystal growth inhibitor. Further, bulky side groups render a molecule inactive as a crystal growth poison, although it will still inhibit by other mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Termine, J. D., Conn, K. M.: Inhibition of apatite formation by phosphorylated metabolites and macromolecules, Calcif. Tissue Res.22:149–157, 1976

    Article  PubMed  CAS  Google Scholar 

  2. Termine, J. D., Peckauskas, R. A., Posner, A. S.: Calcium phosphate formationin vitro II. Effects of environment on amorphous-crystalline transformation, Arch. Biochem. Biophys.140:318–325, 1970

    Article  PubMed  CAS  Google Scholar 

  3. Fleisch, H., Bisaz, S.: Isolation from urine of pyrophosphate, a calcification inhibitor, Am. J. Physiol.203:671–675, 1962

    PubMed  CAS  Google Scholar 

  4. Van Den Berg, C. J., Hill, L. F., Stanbury, S. W.: Inositol phosphates and phytic acid as inhibitors of biological calcification in the rat, Clin. Sci.43:377–383, 1972

    PubMed  Google Scholar 

  5. Williams, G., Sallis, J. D.: Structure-activity relationship of inhibitors of hydroxyapatite formation, Biochem. J.184:181–184, 1979

    PubMed  CAS  Google Scholar 

  6. Williams, G., Holdsworth, E. S., Sallis, J. D.: Phosphocitrate, a new compound for consideration in the control of biological calcification, Clin. Exp. Pharm. Physiol.7:42–43, 1980

    Google Scholar 

  7. Meyer, J. L., Nancollas, G. H.: The influence of multidentate organic phosphates on the crystal growth of hydroxyapatite, Calcif. Tissue Res.13:295–303, 1973

    Article  PubMed  CAS  Google Scholar 

  8. Hay, D. I., Moreno, E. C., Schlesinger, D. H.: Phosphoprotein-inhibitors of calcium phosphate precipitation from salivary secretions, Inorgan. Perspect. Biol. Med.2:271–285, 1979

    CAS  Google Scholar 

  9. Robertson, W. G., Fleisch, H.: The effect of imidodiphosphate (P-N-P) on the precipitation and dissolution of calcium phosphatein vitro, Biochem. Biophys. Acta222:677–680, 1970

    PubMed  CAS  Google Scholar 

  10. Yount, R. G.: Adenylylimidodiphosphate and guanylylimidodiphosphate, Methods Enzymol.138C:420–427, 1974

    Article  Google Scholar 

  11. Williams, G., Sallis, J. D.: The synthesis of unlabelled and32P-labelled phosphocitrate and analytical systems for its identification, Anal. Biochem.102:365–373, 1980

    Article  PubMed  CAS  Google Scholar 

  12. Meyer, J. L., Eanes, E. D.: A thermodynamic analysis of the amorphous to crystalline calcium phosphate transformation, Calcif. Tissue Res.25:59–68, 1978

    Article  PubMed  CAS  Google Scholar 

  13. Termine, J. D., Eanes, E. D.: Comparative chemistry of amorphous and apatitic calcium phosphate preparations, Calcif. Tissue Res.10:171–197, 1972

    Article  PubMed  CAS  Google Scholar 

  14. Eanes, E. D., Termine, J. D., Nylen, M. U.: An electron microscope study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite, Calcif. Tissue Res.12:143–160, 1976

    Article  Google Scholar 

  15. Francis, M. D.: The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates, Calcif. Tissue Res.3:151–162, 1969

    Article  PubMed  CAS  Google Scholar 

  16. Boskey, A. L., Posner, A. S.: Conversion of amorphous calcium phosphate to microcrystalline hydroxyapatite. A pH dependent solution-mediated, solid-solid conversion, J. Phys. Chem.77:2312–2314, 1973

    Article  Google Scholar 

  17. Despotavic, R., Filipovic-Vincekovic, N., Füredi-Milhofer, H.: Precipitation of calcium phosphates from electrolyte solutions. III. Radiometric studies of the kinetics of precipitation and aging of calcium phosphates, Calcif. Tissue Res.18:13–26, 1975

    Google Scholar 

  18. Nancollas, G. H., Mohan, M. S.: The growth of hydroxyapatite crystals, Arch. Oral Biol.15:731–745, 1970

    Article  PubMed  CAS  Google Scholar 

  19. Williams, G., Sallis, J. D.: The sources of phosphocitrate and its influential role in inhibiting calcium phosphate and calcium oxalate crystallization, Proc. Fourth Int. Symp. Urolith. Res. 1980, in press

  20. Tew, W. P., Mahle, C., Benavides, J., Howard, J. E., Lehninger, A. L.: Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxyapatite crystal growth, Biochemistry19:1983–1988, 1980

    Article  PubMed  CAS  Google Scholar 

  21. Wuthier, R. E., Eanes, E. D.: Effect of phospholipids on the transformation of amorphous calcium phosphate to hydroxyapatitein vitro, Calcif. Tissue Res.19:197–210, 1975

    PubMed  CAS  Google Scholar 

  22. Krane, S. M., Glimcher, M. J.: Transphosphorylation from nucleoside di- and triphosphates by apatite crystals, J. Biol. Chem.237:2991–2998, 1962

    PubMed  CAS  Google Scholar 

  23. Fleisch, H., Russell, R. G. G., Bisaz, S., Termine, J. D., Posner, A. S.: Influence of pyrophosphate on the transformation of amorphous to crystalline calcium phosphate, Calcif. Tissue Res.2:49–59, 1968

    Article  CAS  Google Scholar 

  24. Blumenthal, N. C., Betts, F., Posner, A. S.: Stabilization of amorphous calcium phosphate by Mg and ATP, Calcif. Tissue Res.23:245–250, 1977

    Article  PubMed  CAS  Google Scholar 

  25. Fleisch, H.: Inhibitors and promoters of stone formation, Kidney Int.13:361–371, 1978

    PubMed  CAS  Google Scholar 

  26. Posner, A. S., Betts, F.: Synthetic amorphous calcium phosphate and its relation to bone mineral structure, Acc. Chem. Res.8:273–280, 1975

    Article  CAS  Google Scholar 

  27. Posner, A. S., Betts, F., Blumenthal, N. C.: Properties of nucleating systems, Metab. Bone Dis.1:179–184, 1978

    Article  CAS  Google Scholar 

  28. Kawasaki, T.: Theory of chromatography of rigid molecules on hydroxyapatite columns with small loads. IV. Estimation of the adsorption energy of nucleoside polyphosphates, J. Chromatogr.151:95–112, 1978

    Article  CAS  Google Scholar 

  29. Jung, A., Bisaz, S., Fleisch, H.: The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals, Calcif. Tissue Res.11:269–280, 1973

    PubMed  CAS  Google Scholar 

  30. Taves, D. R., Reedy, R. C.: A structural basis for the transphosphorylation of nucleotides with hydroxyapatite, Calcif. Tissue Res.3:284–292, 1969

    Article  PubMed  CAS  Google Scholar 

  31. Blumenthal, N. C., Betts, F., Posner, A. S.: Nucleotide stabilization of amorphous calcium phosphate, Mater. Res. Bull.10:1055–1060, 1975

    Article  CAS  Google Scholar 

  32. Boskey, A. L., Posner, A. S.: Magnesium stabilization of amorphous calcium phosphate: a kinetic study, Mater. Res. Bull.9:907–916, 1974

    Article  CAS  Google Scholar 

  33. Blumenthal, N. C., Posner, A. S., Silverman, L. D., Rosenberg, L. C.: Effect of proteoglycans onin vitro hydroxyapatite formation, Calcif. Tissue Int.27:75–82, 1979

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, G., Sallis, J.D. Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation. Calcif Tissue Int 34, 169–177 (1982). https://doi.org/10.1007/BF02411229

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02411229

Key words

Navigation